Celsion Corporation (NASDAQ: CLN)
Celsion Corporation (NASDAQ: CLN) is committed to developing and commercializing oncology drugs including tumor-targeting treatments. The company has research, license…
Blog
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT)
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development stage company, is focused on safer, more effective, less invasive and more…
Cell Therapeutics, Inc. (NASDAQ: CTIC)
Cell Therapeutics, Inc. (NASDAQ: CTIC) is focused on leading the biopharmaceutical industry with their diversified portfolio of proprietary oncology drugs.…
Protalex, Inc. (OTC BB: PRTX)
Protalex, Inc. (OTC BB: PRTX), a biotechnology company, is focused on developing a new class of drugs designed to treat…
Prospect Acquisition Corporation (AMEX: PAX)
Prospect Acquisition Corporation (AMEX: PAX) is a newly organized blank check company formed for the purpose of acquiring control of,…
Cell Genesys, Inc. (NASDAQ: CEGE)
Cell Genesys, Inc. (NASDAQ: CEGE) has their focus on developing and commercializing novel biological therapies for cancer patients. GVAX® cancer…
Celgene Corporation (NASDAQ: CELG)
Celgene Corporation (NASDAQ: CELG), a multinational biopharmaceutical company, is dedicated improving the lives of patients worldwide by delivering novel and…
Pro-Pharmaceuticals, Inc. (AMEX: PRW)
Pro-Pharmaceuticals, Inc. (AMEX: PRW), a development-stage company, is focused on the discovery, development, and commercialization of first-in-class, targeted therapeutic compounds…
Prana Biotechnology Ltd. (NASDAQ: PRAN)
Prana Biotechnology Ltd. (NASDAQ: PRAN) has developed a proprietary portfolio of class-leading chemical compounds. The company combines this portfolio of…
Cavico Corp. (OTC BB: CVIC)
Cavico Corp. (OTC BB: CVIC), a major infrastructure construction, infrastructure investment and natural resources conglomerate headquartered in Hanoi, Vietnam, is…